R. Fontana

发表

Side-Chain Modified Ergosterol and Stigmasterol Derivatives as Liver X Receptor Agonists.

G. Cruciani, E. Carosati, G. Bocci, 2017, Journal of medicinal chemistry.

Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses

Sandro Sonnino, J. Gustafsson, C. Doglioni, 2010, Nature Medicine.

The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice

C. Doglioni, C. Bordignon, G. Corna, 2016, Cancer Immunology, Immunotherapy.

Detection and Functional Analysis of Tumor-Derived LXR Ligands.

R. Fontana, V. Russo, A. Paniccia, 2016, Methods in molecular biology.

self, viral and tumor antigens between dying and dendritic cells and edits the cross-presentation of The pattern recognition receptor PTX3 is recruited at the synapse

A. Mantovani, D. Accapezzato, V. Barnaba, 2013 .

The pattern recognition receptor PTX3 is recruited at the synapse between dying and dendritic cells, and edits the cross-presentation of self, viral, and tumor antigens.

A. Mantovani, D. Accapezzato, V. Barnaba, 2006, Blood.

Prognostic role of liver X receptor‐alpha in resected stage II and III non‐small‐cell lung cancer

G. Melloni, P. Zannini, C. Doglioni, 2018, The clinical respiratory journal.

Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity.

C. Bordignon, F. Ciceri, C. Traversari, 2007, The Journal of clinical investigation.

An Efficient Strategy to Induce and Maintain In Vitro Human T Cells Specific for Autologous Non-Small Cell Lung Carcinoma

G. Melloni, G. Canderan, P. Dellabona, 2010, PloS one.

Oxysterols recruit tumor-supporting neutrophils within the tumor microenvironment

C. Traversari, R. Fontana, Laura Raccosta, 2013, Oncoimmunology.

Nuclear receptor ligands induce TREM-1 expression on dendritic cells: analysis of their role in tumors

G. Melloni, M. Colonna, M. Mattioli, 2018, Oncoimmunology.

Cholesterol metabolites and tumor microenvironment: the road towards clinical translation

D. Maggioni, R. Fontana, Laura Raccosta, 2015, Cancer Immunology, Immunotherapy.

The oxysterol–CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils

J. Gustafsson, M. Trincavelli, C. Martini, 2013, The Journal of experimental medicine.

The in vivo targeting of tumor antigens to DCs by administration of transduced autologous lymphocytes results in robust and prolonged immunization: Pre-clinical validation and results of a pilot clinical studies of vaccination for metastatic melanoma.

C. Bordignon, F. Ciceri, C. Traversari, 2006, Journal of Clinical Oncology.

Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients.

P. Coulie, C. Doglioni, C. Bordignon, 2009, Blood.

Clinical and immunologic responses in melanoma patients vaccinated with MAGE‐A3‐genetically modified lymphocytes

F. Fazio, L. Gianolli, P. Coulie, 2013, International journal of cancer.

Inhibition of CCR7/CCL19 axis in lesional skin is a critical event for clinical remission induced by TNF blockade in patients with psoriasis.

Gianfranco Altomare, Riccardo L Rossi, Marco Diani, 2013, The American journal of pathology.

Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients.

P. Coulie, C. Doglioni, C. Bordignon, 2009, Blood.

Inhibition of CCR7/CCL19 axis in lesional skin is a critical event for clinical remission induced by TNF blockade in patients with psoriasis.

C. Moscheni, M. Diani, G. Altomare, 2013, The American journal of pathology.

Abstract LB-346: The Oxysterol-CXCR2 axis plays a key role in the recruitment of tumor promoting neutrophils.

M. Trincavelli, C. Martini, C. Doglioni, 2013 .